Krka, d. d. logo

Krka, d. d.

TickerKRK.WAVenueWSESectorHealthcarePrimary listingBeta0.41
PLN 1,128-0.35%
FinScore63

Krka, d. d. is a Slovenia-based company in the Healthcare sector with a market capitalisation of $8.8B. Its FinScore is 63/100; its highest-scoring layer is Momentum (88) and its lowest is Value (36). The shares trade at 18.7x trailing earnings and are up 32% year to date.

Market cap
$8.8B
P/E (TTM)
18.7x
Dividend yield (TTM)
3.48%
ROE
17.2%

Share price performance

Loading chart…

About Krka, d. d.

www.krka.biz

Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.

Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
HQ
Slovenia
Fiscal year-end
December
Trading currency
PLN
Reporting currency
EUR
Fundamentals updated
87 days ago
Market
Market cap
$8.8B
Shares outstanding
30.3M
P/E (TTM)
18.7x
Dividend yield (TTM)
3.48%
Beta (issuer)
0.46
Revenue (latest FY)
€2.0B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall63
Quality83
Growth38
Value36
Momentum88
Relative Strength83

Snapshot

Ownership

Free float
65.2%
Shares outstanding
30.3M

Holder data is not available for this company yet.

Sign up or log in to see Analysis

Analysis for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.